Dr. Anderson has a combined expertise in both protein and small molecule mass spectrometry. His current focus is hydrogen/deuterium exchange mass spectrometry (HDX-MS) for characterization of biopharmaceuticals and proteins. Additionally, he is involved in method development and measurement improvement of HDX-MS. He is currently President of the Washington Chromatography Discussion Group.
He joined NIST as a graduate student with advisors Dr. Illarion Turko (NIST) and Dr. Catherine Fenselau (UMD). His doctoral research focused on mass spectrometry quantification of histone post-translational modifications and HDAC isoforms in neural tissues to study neurodegeneration and Alzheimer's disease. His early doctoral research focused on metabolomics to identify prospective drug targets for the treatment of diabetes. After completing his PhD, he was awarded a NIST-NRC postdoctoral research associateship to develop HDX-MS methods for membrane proteins with advisor Dr. Jeffrey Hudgens.
2015 National Research Council Postdoctoral Research Associateship
2016 ASMS Sanibel Conference Travel Award
2014 U.S. HUPO Travel Award